Vanguard Group
ACHC icon

Vanguard Group’s Acadia Healthcare ACHC Stock Holding History

Vanguard Group’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$133M Sell
9,350,959
-66,086
-0.7% -$1.25M ﹤0.01% 1738
2025
Q3 		$233M Buy
9,417,045
+681,278
+8% +$15.2M ﹤0.01% 1467
2025
Q2 		$198M Sell
8,735,767
-66,014
-0.8% -$1.56M ﹤0.01% 1504
2025
Q1 		$267M Sell
8,801,781
-78,676
-0.9% -$3M ﹤0.01% 1337
2024
Q4 		$352M Sell
8,880,457
-10,986
-0.1% -$496K 0.01% 1249
2024
Q3 		$564M Sell
8,891,443
-6,402
-0.1% -$462K 0.01% 966
2024
Q2 		$601M Buy
8,897,845
+41,409
+0.5% +$2.89M 0.01% 884
2024
Q1 		$702M Sell
8,856,436
-4,991
-0.1% -$408K 0.01% 816
2023
Q4 		$689M Buy
8,861,427
+30,296
+0.3% +$2.24M 0.02% 793
2023
Q3 		$621M Buy
8,831,131
+26,379
+0.3% +$1.97M 0.02% 792
2023
Q2 		$701M Sell
8,804,752
-302,978
-3% -$21.9M 0.02% 737
2023
Q1 		$658M Buy
9,107,730
+145,268
+2% +$11.3M 0.02% 750
2022
Q4 		$738M Buy
8,962,462
+204,458
+2% +$16.9M 0.02% 688
2022
Q3 		$685M Buy
8,758,004
+131,959
+2% +$10.5M 0.02% 678
2022
Q2 		$583M Buy
8,626,045
+196,198
+2% +$13.7M 0.02% 768
2022
Q1 		$552M Buy
8,429,847
+69,730
+0.8% +$4.05M 0.01% 896
2021
Q4 		$507M Buy
8,360,117
+19,458
+0.2% +$1.16M 0.01% 987
2021
Q3 		$532M Buy
8,340,659
+5,620
+0.1% +$355K 0.01% 938
2021
Q2 		$523M Buy
8,335,039
+199,034
+2% +$12.5M 0.01% 964
2021
Q1 		$465M Buy
8,136,005
+214,386
+3% +$11.6M 0.01% 996
2020
Q4 		$398M Buy
7,921,619
+420,557
+6% +$16.8M 0.01% 1010
2020
Q3 		$221M Sell
7,501,062
-450,671
-6% -$13.1M 0.01% 1213
2020
Q2 		$200M Sell
7,951,733
-519,041
-6% -$13M 0.01% 1269
2020
Q1 		$155M Buy
8,470,774
+186,886
+2% +$5.35M 0.01% 1281
2019
Q4 		$275M Buy
8,283,888
+156,015
+2% +$4.89M 0.01% 1195
2019
Q3 		$253M Buy
8,127,873
+129,460
+2% +$3.94M 0.01% 1194
2019
Q2 		$280M Sell
7,998,413
-9,643
-0.1% -$312K 0.01% 1151
2019
Q1 		$235M Buy
8,008,056
+65,446
+0.8% +$1.85M 0.01% 1238
2018
Q4 		$204M Buy
7,942,610
+543,528
+7% +$18.8M 0.01% 1236
2018
Q3 		$260M Buy
7,399,082
+183,698
+3% +$7.32M 0.01% 1210
2018
Q2 		$295M Buy
7,215,384
+259,410
+4% +$10.5M 0.01% 1088
2018
Q1 		$273M Buy
6,955,974
+187,947
+3% +$6.89M 0.01% 1093
2017
Q4 		$221M Buy
6,768,027
+90,416
+1% +$3.13M 0.01% 1250
2017
Q3 		$319M Buy
6,677,611
+423,079
+7% +$20.6M 0.01% 967
2017
Q2 		$309M Buy
6,254,532
+511,299
+9% +$22.6M 0.02% 964
2017
Q1 		$250M Buy
5,743,233
+431,550
+8% +$17.5M 0.01% 1067
2016
Q4 		$176M Sell
5,311,683
-49,182
-0.9% -$1.91M 0.01% 1258
2016
Q3 		$266M Buy
5,360,865
+380,311
+8% +$19.8M 0.02% 917
2016
Q2 		$276M Buy
4,980,554
+283,624
+6% +$16.6M 0.02% 870
2016
Q1 		$259M Buy
4,696,930
+884,513
+23% +$50.5M 0.02% 871
2015
Q4 		$238M Buy
3,812,417
+77,404
+2% +$5.04M 0.02% 898
2015
Q3 		$248M Buy
3,735,013
+57,247
+2% +$4.4M 0.02% 870
2015
Q2 		$288M Buy
3,677,766
+665,589
+22% +$47.9M 0.02% 850
2015
Q1 		$216M Buy
3,012,177
+240,668
+9% +$15.4M 0.01% 995
2014
Q4 		$170M Buy
2,771,509
+42,478
+2% +$2.47M 0.01% 1075
2014
Q3 		$132M Buy
2,729,031
+48,269
+2% +$2.36M 0.01% 1173
2014
Q2 		$122M Buy
2,680,762
+530,311
+25% +$23.3M 0.01% 1261
2014
Q1 		$97M Buy
2,150,451
+69,537
+3% +$3.43M 0.01% 1367
2013
Q4 		$98.5M Buy
2,080,914
+75,854
+4% +$3.3M 0.01% 1321
2013
Q3 		$79.1M Buy
2,005,060
+88,328
+5% +$3.28M 0.01% 1412
2013
Q2 		$63.4M Buy
+1,916,732
New +$62.2M 0.01% 1468

Other funds holding ACHC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ABI
Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Vanguard Group's ACHC Position: Q4 2025 in Review

Vanguard Group reduced its Acadia Healthcare (ACHC) stake by 0.7% in Q4 2025, selling an estimated $1.25M and leaving 9,350,959 shares worth $133M. The position accounts for ﹤0.01% of the portfolio, ranked #1738.

Vanguard Group first reported a position in ACHC in Q2 2013 and has held it in 51 quarters since. The position peaked at $738M in Q4 2022. 254 funds tracked by Wall St. Rank hold ACHC as of Q4 2025.

  • Vanguard Group held 9,350,959 shares of Acadia Healthcare worth $133M as of Q4 2025.
  • Vanguard Group sold 66,086 Acadia Healthcare shares in Q4 2025, an estimated $1.25M.
  • Acadia Healthcare made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1738 holding.
  • Vanguard Group first reported a position in Acadia Healthcare in Q2 2013 and has held it in 51 quarters since.
  • Vanguard Group's Acadia Healthcare position peaked at $738M in Q4 2022.
  • 254 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.